## Abstract The preparation of deuterium labelled catecholamines and their metabolites is described. The procedures involve simple treatment of the compounds in DC1/D~2~O solution. Mass spectra of these labelled compounds — as their PFP or TFA derivative — are presented. The relative intensity of i
Preparation and photolysis of deuterium-labelled rhodopsin analogues
✍ Scribed by M. R. Fransen; I. Palings; J. Lugtenburg; P. A. A. Jansen; G. W. T. Groenendijk
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 895 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0165-0513
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The compounds 18‐ and 19‐trideutero‐11__‐cis__‐retinal, > 99% pure, with over 98% and 99% trideuterium incorporation were synthesized together with the corresponding all‐trans derivatives. Rhodopsins were prepared from bovine opsin and 18‐ and 19‐trideutero‐11‐cis‐retinal. 18‐ and 19‐trideutero‐all‐trans‐retinal were isolated as oximes after photolysis of the corresponding rhodopsins. The oximes showed the same deuterium incorporation as the starting 18‐ and 19‐trideutero‐11‐cis‐retinals and as those oximes obtained by denaturation of 18‐ and 19‐trideuterorhodopsin in the dark.
These results demonstrate that during rhodopsin photolysis no detectable exchange of D or H occurs at carbon atoms 18 and 19.
These facts, together with Resonance Raman data of 18‐trideutero‐bathorhodopsin and 5‐demethyl‐bathorhodopsin, establish that the primary step in rhodopsin photochemistry is not a phototautomerization involving the 5‐CH~3~ group. With respect to the possibility that the primary step is a phototautomerization involving the 9‐CH~3~ group, the situation is less clear.
At this time tile experimental evidence of the various research disciplines is insufficiently conclusive to establish unambiguously which of the two possibilities, cis‐trans photoisomerization or phototautomerization involving the 9‐CH~3~ group, is the primary event in visual photochemistry.
📜 SIMILAR VOLUMES
## Abstract The synthesis of d, l, ‐12‐bromocamptothecin (**2d**) from camptothecin (**1**) is described. Reduction of the bromo derivative **2d** with tritium gas in the presence of palladium on carbon afforded d, l‐camptothecin 12‐^3^H having a specific activity of 29 Ci/mmol. A simpler labelling
## Abstract The chemoenzymatic preparation of optically‐active [3,3,3‐^2^H~3~]‐ibuprofen and [2‐^2^H]‐ibuprofen are described.
For the first time the total synthesis of the peptaibol zervamicin IIB is described. Synthesis of this peptaibol was achieved by the Fmoc/tert-butyl strategy in solution using a fragment condensation approach. Three fragments of zervamicin IIB were obtained by stepwise elongation with Fmoc amino aci
## Abstract The preparations of guvacine hydrochloride, in which a proton in position 2 (**11**) and protons in positions 2 and 5 (**10**) are selectively exchanged by deuterium, and of [2,6‐^2^H]isoguvacine hydrobromide (**14a**) are described. The deuterium labelled guvacine salts 10 and 11 were